PADI4 and multiple sclerosis: This possibility is supported by numerous reports reveling PAD4-mediated citrullination in various neuropathological conditions, such as multiple sclerosis (Sarswat et al. 2017), Alzheimer’s disease (Ishigami et al. 2005), and cerebral ischemia (Seol et al. 2024).